Mankind Pharma Limited (BOM:543904)
India · Delayed Price · Currency is INR 2,417.35
+12.40 (0.52%)
At close: Jun 19, 2026
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 1.05 trillion as of June 22, 2026. Its market cap has increased by 5.18% in one year.
Market Cap
1.05T
Enterprise Value
1.09T
Revenue
142.78B
Ranking
n/a
PE Ratio
54.78
Stock Price
2,417.35
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 1.05T, an increase of 83.92%. That is a compound annual growth rate of 21.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 1.05T | 15.57% |
| Dec 31, 2025 | 906.73B | -23.70% |
| Dec 31, 2024 | 1.19T | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.50T |
| Lupin | 1.08T |
| Dr. Reddy's Laboratories | 1.06T |
| Abbott India | 557.17B |
| GlaxoSmithKline Pharmaceuticals | 395.20B |
| J. B. Chemicals & Pharmaceuticals | 351.51B |
| Rubicon Research | 224.36B |
| AstraZeneca Pharma India | 210.17B |